Hemp Inc HEMP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HEMP is a good fit for your portfolio.
News
-
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Hemp, Inc. Announces Significant Progress in Hemp Seed Meal Approval for Laying Hen Diets
-
Hemp, Inc. Reports: Hemp-Based Foods Market Set to Reach $8.36 Billion by 2028
-
Hemp, Inc. Profiled in Latest Global Report
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $23,740.50
- Volume/Avg
- 100,000 / 18.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Hemp Inc is engaged in offering industrial hemp and the myriad of clean, green sustainable products that industrial hemp offers to the world. Hemp products are eco-friendly, healthy, and can often replace petroleum-based products. Its product line includes Bubba Kush hemp, Pre-rolls, Fortified Pre-rolls, Caviar/Moon Rocks, and Diamonds. It produces lost circulation material (LCM), called DrillWall, which can be sold to the oil and gas drilling industry, along with an all-green natural oil spill absorbent, a second industrial kenaf-hemp product called Spill-Be-Gone.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.hempinc.com
Valuation
|
Metric
|
HEMP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
HEMP
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
HEMP
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rcwvgnslt | Qpr | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Xxtdwvvhjb | Rvmsmt | $68.4 Bil | |
HLN
| Haleon PLC ADR | Swskqxjtn | Msms | $37.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Pxftzdnf | Prv | $14.5 Bil | |
VTRS
| Viatris Inc | Zdqzkzcx | Znyrf | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zjtpjkgr | Mtcs | $12.0 Bil | |
CTLT
| Catalent Inc | Myqsrqwz | Twstwl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Jhhrdrnv | Tkv | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Lwbdqxwkk | Wxzq | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qscnxngst | Wjrjws | $3.5 Bil |